NantHealth had a great first day of trading Thursday, as shares jumped by nearly a third above the initial public offering price of $14 to close at $18.59.
NantHealth, the health IT, genomics and analytics division of Dr. Patrick Soon-Shiong’s NantWorks business empire, raised $91 million in the IPO. The 6.5 million shares of common stock offered on the Nasdaq represent about 5.5 percent of the company.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
The Culver City, California-based company said in its IPO registration last month that Soon-Shiong would own 58 percent of all shares. He will not, however be full-time with NantHealth; instead, he will devote the majority of his time to clinical-stage immunotherapy company NantKwest, which Soon-Shiong took public last year.
Still, he is going to be calling the shots at NantHealth. “I’m committed as a CEO to make this company one of the most important companies in transforming healthcare,” Soon-Shiong said on CNBC’s “Squawk on the Street” Thursday.
Photo: Kevork Djansezian/Getty Images